ArticleClinical case reports2026
Diagnosis and Treatment Report of a Case of Small Hepatocellular Carcinoma With Left Adrenal Metastasis and Hemorrhage in an Elderly Male Hepatitis B Virus Carrier.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 64-year-old male hepatitis B virus (HBV) carrier was admitted to the hospital due to long-term left lumbodorsal pain. He reported having suffered from lumbodorsal pain for 3 months. After visiting our hospital, he underwent a complete urinary system computed tomography (CT) scan, which revealed masses in the thyroid gland and liver. Subsequent efforts focused on the diagnosis, treatment, and prognostic follow-up of this disease. The key focuses of this case are as follows: the potential of small hepatocellular carcinoma for distant metastasis; the role of combined detection of alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II) in monitoring the disease condition throughout the entire treatment course of liver cancer; the possibility of hemorrhage in adrenal metastatic lesions; and the comprehensive treatment plan formulated after multidisciplinary discussions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.